Table 2 Univariate factor analysis for factor associations with the responsiveness of refractory exudative fluid at 1 week after injection.
Responsiveness of the refractory fluid (IRF + SRF) | |||
|---|---|---|---|
Continuous variables | Mean (SD) | Correlation (p value) | |
Age | 78.5 years (6.1) | r 0.22 (p = 0.15) | |
Combined baseline volume of IRF + SRF | 248 µm3 (276) | r −0.43 (p = 0.003) | |
PED volume at baseline | 989 µm3 (990) | r −0.40 (p = 0.007) | |
Subfoveal choroidal thickness | 170 µm (65) | r −0.11 (p = 0.48) | |
Feeder vessel diameter on ICGA | 129 µm (52) | r 0.04 (p = 0.79) | |
Visual acuity in logMAR | 0.24 (0.23) | r −0.09 (p = 0.004) | |
CRT change at initiation of anti-VEGF treatment | −84 µm (148) | r 0.14 (p < 0.0001) | |
Systolic blood pressure | 140 mmHg (20) | r 0.05 (p = 0.72) | |
Diastolic blood pressure | 78 mmHg (11) | r 0.10 (p = 0.52) | |
Categorical variables | n | Mean (SD) | Anova p value |
Sex | Females 29 Males 12 | 0.66 (0.06) 0.67 (0.10) | p = 0.92 |
Macular neovascularization type | Type 1 = 36 Type 2 = 8 | 0.65 (0.06) 0.75 (0.11) | p = 0.40 |
PCV on ICGA | Present = 7 Absent = 38 | 0.66 (0.06) 0.74 (0.13) | p = 0.56 |
Inflammatory signs on fluorescein angiography | Present = 5 Absent = 40 | 0.66 (0.05) 0.74 (0.15) | p = 0.60 |
Vitreomacular adherence on OCT | Present = 7 Absent = 38 | 0.84 (0.13) 0.64 (0.05) | p = 0.14 |
Dryness achieved after initial loading dose | Yes 15 (33%) No 30 (67%) | 0.68 (0.06) 0.77 (0.04) | p = 0.25 |
Fibrosis | Present = 4 Absent = 41 | 0.76 (0.12) 0.74 (0.04) | p = 0.89 |
Atrophy | Present = 6 Absent = 39 | 0.74 (0.10) 0.74 (0.04) | p = 0.98 |
